NCT01916369View on ClinicalTrials.gov

Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 16, 2018

Study Completion Date

January 16, 2018

Conditions
Peripheral Arterial Disease
Interventions
BIOLOGICAL

CTX DP

Single dose treatment consisting of 10 injections (20, 50 or 80 million cells) into the gastrocnemius muscle near to the damaged area

Trial Locations (1)

DD1 4HN

Ninewells Hospital, Dundee

All Listed Sponsors
lead

ReNeuron Limited

INDUSTRY

NCT01916369 - Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia | Biotech Hunter | Biotech Hunter